GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Shiller PE Ratio

China National Accord Medicines (SZSE:000028) Shiller PE Ratio : 16.24 (As of May. 27, 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Shiller PE Ratio?

As of today (2024-05-27), China National Accord Medicines's current share price is ¥38.65. China National Accord Medicines's E10 for the quarter that ended in Mar. 2024 was ¥2.38. China National Accord Medicines's Shiller PE Ratio for today is 16.24.

The historical rank and industry rank for China National Accord Medicines's Shiller PE Ratio or its related term are showing as below:

SZSE:000028' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.07   Med: 23.66   Max: 85.25
Current: 16.24

During the past years, China National Accord Medicines's highest Shiller PE Ratio was 85.25. The lowest was 10.07. And the median was 23.66.

SZSE:000028's Shiller PE Ratio is ranked better than
62.96% of 54 companies
in the Medical Distribution industry
Industry Median: 18.66 vs SZSE:000028: 16.24

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

China National Accord Medicines's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.700. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥2.38 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


China National Accord Medicines Shiller PE Ratio Historical Data

The historical data trend for China National Accord Medicines's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Shiller PE Ratio Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.86 18.31 13.64 11.32 12.33

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.05 19.04 13.58 12.33 12.92

Competitive Comparison of China National Accord Medicines's Shiller PE Ratio

For the Medical Distribution subindustry, China National Accord Medicines's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Shiller PE Ratio falls into.



China National Accord Medicines Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

China National Accord Medicines's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=38.65/2.38
=16.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Accord Medicines's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, China National Accord Medicines's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.7/115.2271*115.2271
=0.700

Current CPI (Mar. 2024) = 115.2271.

China National Accord Medicines Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.378 98.200 0.444
201409 0.337 98.900 0.393
201412 0.310 99.000 0.361
201503 0.418 99.900 0.482
201506 0.404 99.500 0.468
201509 0.396 100.500 0.454
201512 0.467 100.600 0.535
201603 0.462 102.200 0.521
201606 0.737 101.400 0.837
201609 0.455 102.400 0.512
201612 0.501 102.600 0.563
201703 0.492 103.200 0.549
201706 0.508 103.100 0.568
201709 0.444 104.100 0.491
201712 0.457 104.500 0.504
201803 0.523 105.300 0.572
201806 0.631 104.900 0.693
201809 0.512 106.600 0.553
201812 0.512 106.500 0.554
201903 0.538 107.700 0.576
201906 0.631 107.700 0.675
201909 0.554 109.800 0.581
201912 0.554 111.200 0.574
202003 0.446 112.300 0.458
202006 0.708 110.400 0.739
202009 0.638 111.700 0.658
202012 0.723 111.500 0.747
202103 0.592 112.662 0.605
202106 0.738 111.769 0.761
202109 0.600 112.215 0.616
202112 0.469 113.108 0.478
202203 0.454 114.335 0.458
202206 0.756 114.558 0.760
202209 0.670 115.339 0.669
202212 0.790 115.116 0.791
202303 0.650 115.116 0.651
202306 0.840 114.558 0.845
202309 0.650 115.339 0.649
202312 0.730 114.781 0.733
202403 0.700 115.227 0.700

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China National Accord Medicines  (SZSE:000028) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


China National Accord Medicines Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines